Lactobacillus brevis bacteriophage Lac-BRP-1 and use thereof for inhibiting Lactobacillus brevis proliferation
US10227570B2 · kind B2 · utility
1Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2016 |
| Grant date | Mar 12, 2019 |
| Priority date | — |
| Expiry date | Jan 5, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02E50/10
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to a Siphoviridae bacteriophage Lac-BRP-1 that is isolated from the nature and can kill Lactobacillus brevis cells specifically, which has a genome represented by the nucleotide sequence of SEQ. ID. NO: 1 (Accession NO: KCTC 12659BP), and a method for preventing and treating the contaminations of Lactobacillus brevis by using the composition comprising the bacteriophage as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.